메뉴 건너뛰기
Antimicrobial Agents and Chemotherapy
Volumn 59, Issue 6, 2015, Pages 3281-3289
Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae
Author keywords

[No Author keywords available]
Indexed keywords

IMIPENEM; PORIN; PROTEIN OMPK36; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; OUTER MEMBRANE PROTEIN;
EID: 84982085148     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05100-14     Document Type: Article
Times cited : (39)
References (59)
  • 2
    • 84884597711 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
    • Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
    • (2013) Antibiotic Resistance Threats in the United States
  • 3
    • 24044518439 scopus 로고    scopus 로고
    • Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: Molecular epidemiology and in vitro activity of polymyxin B and other agents
    • Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D. 2005. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56:128-132. http://dx.doi.org/10.1093/jac/dki175.
    • (2005) J Antimicrob Chemother , vol.56 , pp. 128-132
    • Bratu, S.1    Tolaney, P.2    Karumudi, U.3    Quale, J.4    Mooty, M.5    Nichani, S.6    Landman, D.7
  • 6
    • 3042835910 scopus 로고    scopus 로고
    • Emergence of carbapenemresistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City
    • Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, Rahal JJ, Brooks S, Cebular S, Quale J. 2004. Emergence of carbapenemresistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 39:55-60. http://dx.doi.org/10.1086/421495.
    • (2004) Clin Infect Dis , vol.39 , pp. 55-60
    • Bradford, P.A.1    Bratu, S.2    Urban, C.3    Visalli, M.4    Mariano, N.5    Landman, D.6    Rahal, J.J.7    Brooks, S.8    Cebular, S.9    Quale, J.10
  • 8
    • 81255171675 scopus 로고    scopus 로고
    • Predictors of mortality in patients with bloodstream infections caused by KPCproducing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
    • Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, Prekates A, Themeli-Digalaki K, Tsakris A. 2011. Predictors of mortality in patients with bloodstream infections caused by KPCproducing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 17:1798-1803. http://dx.doi.org/10.1111/j.1469-0691.2011.03514.x.
    • (2011) Clin Microbiol Infect , vol.17 , pp. 1798-1803
    • Zarkotou, O.1    Pournaras, S.2    Tselioti, P.3    Dragoumanos, V.4    Pitiriga, V.5    Ranellou, K.6    Prekates, A.7    Themeli-Digalaki, K.8    Tsakris, A.9
  • 9
    • 22144436291 scopus 로고    scopus 로고
    • Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium
    • Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, Quale J. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 165:1430-1435. http://dx.doi.org/10.1001/archinte.165.12.1430.
    • (2005) Arch Intern Med , vol.165 , pp. 1430-1435
    • Bratu, S.1    Landman, D.2    Haag, R.3    Recco, R.4    Eramo, A.5    Alam, M.6    Quale, J.7
  • 10
    • 67349254120 scopus 로고    scopus 로고
    • Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae after treatment with imipenem or meropenem
    • Weisenberg SA, Morgan DJ, Espinal-Witter R, Larone DH. 2009. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem. Diagn Microbiol Infect Dis 64:233-235. http://dx.doi.org/10.1016/j.diagmicrobio.2009.02.004.
    • (2009) Diagn Microbiol Infect Dis , vol.64 , pp. 233-235
    • Weisenberg, S.A.1    Morgan, D.J.2    Espinal-Witter, R.3    Larone, D.H.4
  • 14
    • 77953552925 scopus 로고    scopus 로고
    • Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): An emerging cause of multidrugresistant infection
    • Hirsch EB, Tam VH. 2010. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrugresistant infection. J Antimicrob Chemother 65:1119-1125. http://dx.doi.org/10.1093/jac/dkq108.
    • (2010) J Antimicrob Chemother , vol.65 , pp. 1119-1125
    • Hirsch, E.B.1    Tam, V.H.2
  • 15
    • 62749195559 scopus 로고    scopus 로고
    • The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
    • Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228-236. http://dx.doi.org/10.1016/S1473-3099(09)70054-4.
    • (2009) Lancet Infect Dis , vol.9 , pp. 228-236
    • Nordmann, P.1    Cuzon, G.2    Naas, T.3
  • 16
    • 70349312522 scopus 로고    scopus 로고
    • Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
    • Landman D, Bratu S, Quale J. 2009. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 58:1303-1308. http://dx.doi.org/10.1099/jmm.0.012575-0.
    • (2009) J Med Microbiol , vol.58 , pp. 1303-1308
    • Landman, D.1    Bratu, S.2    Quale, J.3
  • 17
    • 0035044562 scopus 로고    scopus 로고
    • A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
    • Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 47:399-403. http://dx.doi.org/10.1093/jac/47.4.399.
    • (2001) J Antimicrob Chemother , vol.47 , pp. 399-403
    • Wootton, M.1    Howe, R.A.2    Hillman, R.3    Walsh, T.R.4    Bennett, P.M.5    MacGowan, A.P.6
  • 18
    • 84865421487 scopus 로고    scopus 로고
    • Role of ISKpn7 and deletions in blaKPC gene expression
    • Naas T, Cuzon G, Truong HV, Nordmann P. 2012. Role of ISKpn7 and deletions in blaKPC gene expression. Antimicrob Agents Chemother 56: 4753-4759. http://dx.doi.org/10.1128/AAC.00334-12.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 4753-4759
    • Naas, T.1    Cuzon, G.2    Truong, H.V.3    Nordmann, P.4
  • 19
    • 62549121211 scopus 로고    scopus 로고
    • Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. Clinical isolates from the UK
    • Doumith M, Ellington MJ, Livermore DM, Woodford N. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659-667. http://dx.doi.org/10.1093/jac/dkp029.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 659-667
    • Doumith, M.1    Ellington, M.J.2    Livermore, D.M.3    Woodford, N.4
  • 20
    • 0022498009 scopus 로고
    • Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species
    • Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO. 1986. Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 24:330-332.
    • (1986) J Clin Microbiol , vol.24 , pp. 330-332
    • Carlone, G.M.1    Thomas, M.L.2    Rumschlag, H.S.3    Sottnek, F.O.4
  • 21
    • 84875478948 scopus 로고    scopus 로고
    • The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAbetaN) permeabilizes the outer membrane of gram-negative bacteria
    • Lamers RP, Cavallari JF, Burrows LL. 2013. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAbetaN) permeabilizes the outer membrane of gram-negative bacteria. PLoS One 8:e60666. http://dx.doi.org/10.1371/journal.pone.0060666.
    • (2013) PLoS One , vol.8 , pp. e60666
    • Lamers, R.P.1    Cavallari, J.F.2    Burrows, L.L.3
  • 22
    • 44449165917 scopus 로고    scopus 로고
    • Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital
    • Cai JC, Zhou HW, Zhang R, Chen GX. 2008. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 52:2014-2018. http://dx.doi.org/10.1128/AAC.01539-07.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2014-2018
    • Cai, J.C.1    Zhou, H.W.2    Zhang, R.3    Chen, G.X.4
  • 26
    • 0035193696 scopus 로고    scopus 로고
    • Hetero-resistance: An under-recognised confounder in diagnosis and therapy?
    • Rinder H. 2001. Hetero-resistance: an under-recognised confounder in diagnosis and therapy? J Med Microbiol 50:1018-1020.
    • (2001) J Med Microbiol , vol.50 , pp. 1018-1020
    • Rinder, H.1
  • 27
    • 0026085381 scopus 로고
    • Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci
    • Tomasz A, Nachman S, Leaf H. 1991. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 35:124-129. http://dx.doi.org/10.1128/AAC.35.1.124.
    • (1991) Antimicrob Agents Chemother , vol.35 , pp. 124-129
    • Tomasz, A.1    Nachman, S.2    Leaf, H.3
  • 28
    • 0035181254 scopus 로고    scopus 로고
    • A microdilution plating method for population analysis of antibiotic-resistant staphylococci
    • Pfeltz RF, Schmidt JL, Wilkinson BJ. 2001. A microdilution plating method for population analysis of antibiotic-resistant staphylococci. Microb Drug Resist 7:289-295. http://dx.doi.org/10.1089/10766290152652846.
    • (2001) Microb Drug Resist , vol.7 , pp. 289-295
    • Pfeltz, R.F.1    Schmidt, J.L.2    Wilkinson, B.J.3
  • 29
    • 35348861380 scopus 로고    scopus 로고
    • Heteroresistance to penicillin in Streptococcus pneumoniae
    • Morand B, Muhlemann K. 2007. Heteroresistance to penicillin in Streptococcus pneumoniae. Proc Natl Acad Sci U S A 104:14098-14103. http://dx.doi.org/10.1073/pnas.0702377104.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 14098-14103
    • Morand, B.1    Muhlemann, K.2
  • 30
    • 80054855034 scopus 로고    scopus 로고
    • Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of Staphyloccocus aureus
    • Harigaya Y, Ngo D, Lesse AJ, Huang V, Tsuji BT. 2011. Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of Staphyloccocus aureus. BMC Infect Dis 11:287. http://dx.doi.org/10.1186/1471-2334-11-287.
    • (2011) BMC Infect Dis , vol.11 , pp. 287
    • Harigaya, Y.1    Ngo, D.2    Lesse, A.J.3    Huang, V.4    Tsuji, B.T.5
  • 31
    • 0141925619 scopus 로고    scopus 로고
    • Staphylococcus aureus with heterogeneous resistance to vancomycin: Epidemiology, clinical significance, and critical assessment of diagnostic methods
    • Liu C, Chambers HF. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 47: 3040-3045. http://dx.doi.org/10.1128/AAC.47.10.3040-3045.2003.
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 3040-3045
    • Liu, C.1    Chambers, H.F.2
  • 32
    • 84862677946 scopus 로고    scopus 로고
    • Colistin resistance of Acinetobacter baumannii: Clinical reports, mechanisms and antimicrobial strategies
    • Cai Y, Chai D, Wang R, Liang B, Bai N. 2012. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 67:1607-1615. http://dx.doi.org/10.1093/jac/dks084.
    • (2012) J Antimicrob Chemother , vol.67 , pp. 1607-1615
    • Cai, Y.1    Chai, D.2    Wang, R.3    Liang, B.4    Bai, N.5
  • 33
    • 84863155296 scopus 로고    scopus 로고
    • Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii
    • Hung KH, Wang MC, Huang AH, Yan JJ, Wu JJ. 2012. Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii. J Clin Microbiol 50:721-726. http://dx.doi.org/10.1128/JCM.05085-11.
    • (2012) J Clin Microbiol , vol.50 , pp. 721-726
    • Hung, K.H.1    Wang, M.C.2    Huang, A.H.3    Yan, J.J.4    Wu, J.J.5
  • 34
    • 79952817869 scopus 로고    scopus 로고
    • Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: Mechanism and clinical implications
    • Lee HY, Chen CL, Wang SB, Su LH, Chen SH, Liu SY, Wu TL, Lin TY, Chiu CH. 2011. Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents 37:302-308. http://dx.doi.org/10.1016/j.ijantimicag.2010.12.015.
    • (2011) Int J Antimicrob Agents , vol.37 , pp. 302-308
    • Lee, H.Y.1    Chen, C.L.2    Wang, S.B.3    Su, L.H.4    Chen, S.H.5    Liu, S.Y.6    Wu, T.L.7    Lin, T.Y.8    Chiu, C.H.9
  • 35
    • 80053145956 scopus 로고    scopus 로고
    • Investigation of carbapenem heteroresistance among different sequence types of Pseudomonas aeruginosa clinical isolates reveals further diversity
    • Oikonomou O, Panopoulou M, Ikonomidis A. 2011. Investigation of carbapenem heteroresistance among different sequence types of Pseudomonas aeruginosa clinical isolates reveals further diversity. J Med Microbiol 60:1556-1558. http://dx.doi.org/10.1099/jmm.0.032276-0.
    • (2011) J Med Microbiol , vol.60 , pp. 1556-1558
    • Oikonomou, O.1    Panopoulou, M.2    Ikonomidis, A.3
  • 36
    • 33845932934 scopus 로고    scopus 로고
    • Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems
    • Pournaras S, Ikonomidis A, Markogiannakis A, Spanakis N, Maniatis AN, Tsakris A. 2007. Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J Med Microbiol 56:66-70. http://dx.doi.org/10.1099/jmm.0.46816-0.
    • (2007) J Med Microbiol , vol.56 , pp. 66-70
    • Pournaras, S.1    Ikonomidis, A.2    Markogiannakis, A.3    Spanakis, N.4    Maniatis, A.N.5    Tsakris, A.6
  • 37
    • 79952807673 scopus 로고    scopus 로고
    • Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
    • Meletis G, Tzampaz E, Sianou E, Tzavaras I, Sofianou D. 2011. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother 66:946-947. http://dx.doi.org/10.1093/jac/dkr007.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 946-947
    • Meletis, G.1    Tzampaz, E.2    Sianou, E.3    Tzavaras, I.4    Sofianou, D.5
  • 38
    • 84860332763 scopus 로고    scopus 로고
    • Reduced susceptibility to chlorhexidine among extremely-drugresistant strains of Klebsiella pneumoniae
    • Naparstek L, Carmeli Y, Chmelnitsky I, Banin E, Navon-Venezia S. 2012. Reduced susceptibility to chlorhexidine among extremely-drugresistant strains of Klebsiella pneumoniae. J Hosp Infect 81:15-19. http://dx.doi.org/10.1016/j.jhin.2012.02.007.
    • (2012) J Hosp Infect , vol.81 , pp. 15-19
    • Naparstek, L.1    Carmeli, Y.2    Chmelnitsky, I.3    Banin, E.4    Navon-Venezia, S.5
  • 39
    • 77954437585 scopus 로고    scopus 로고
    • Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. Pneumoniae
    • Pournaras S, Kristo I, Vrioni G, Ikonomidis A, Poulou A, Petropoulou D, Tsakris A. 2010. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae. J Clin Microbiol 48:2601-2604. http://dx.doi.org/10.1128/JCM.02134-09.
    • (2010) J Clin Microbiol , vol.48 , pp. 2601-2604
    • Pournaras, S.1    Kristo, I.2    Vrioni, G.3    Ikonomidis, A.4    Poulou, A.5    Petropoulou, D.6    Tsakris, A.7
  • 40
    • 0041527231 scopus 로고    scopus 로고
    • What makes resistance to methicillin heterogeneous?
    • Rohrer S, Maki H, Berger-Bachi B. 2003. What makes resistance to methicillin heterogeneous? J Med Microbiol 52:605-607. http://dx.doi.org/10.1099/jmm.0.05176-0.
    • (2003) J Med Microbiol , vol.52 , pp. 605-607
    • Rohrer, S.1    Maki, H.2    Berger-Bachi, B.3
  • 41
    • 84878595261 scopus 로고    scopus 로고
    • The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureus
    • Deresinski S. 2013. The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureus. J Infect Dis 208: 7-9. http://dx.doi.org/10.1093/infdis/jit136.
    • (2013) J Infect Dis , vol.208 , pp. 7-9
    • Deresinski, S.1
  • 42
    • 75949092532 scopus 로고    scopus 로고
    • Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis
    • Kohanski MA, De Pristo MA, Collins JJ. 2010. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37:311-320. http://dx.doi.org/10.1016/j.molcel.2010.01.003.
    • (2010) Mol Cell , vol.37 , pp. 311-320
    • Kohanski, M.A.1    De Pristo, M.A.2    Collins, J.J.3
  • 43
    • 70349684927 scopus 로고    scopus 로고
    • Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
    • Maor Y, Lago L, Zlotkin A, Nitzan Y, Belausov N, Ben-David D, Keller N, Rahav G. 2009. Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients. BMC Microbiol 9:189. http://dx.doi.org/10.1186/1471-2180-9-189.
    • (2009) BMC Microbiol , vol.9 , pp. 189
    • Maor, Y.1    Lago, L.2    Zlotkin, A.3    Nitzan, Y.4    Belausov, N.5    Ben-David, D.6    Keller, N.7    Rahav, G.8
  • 44
    • 84878284782 scopus 로고    scopus 로고
    • Whole-genome sequencing reveals a link between beta-lactam resistance and synthetases of the alarmone (p)ppGpp in Staphylococcus aureus
    • Mwangi MM, Kim C, Chung M, Tsai J, Vijayadamodar G, Benitez M, Jarvie TP, Du L, Tomasz A. 2013. Whole-genome sequencing reveals a link between beta-lactam resistance and synthetases of the alarmone (p)ppGpp in Staphylococcus aureus. Microb Drug Resist 19:153-159. http://dx.doi.org/10.1089/mdr.2013.0053.
    • (2013) Microb Drug Resist , vol.19 , pp. 153-159
    • Mwangi, M.M.1    Kim, C.2    Chung, M.3    Tsai, J.4    Vijayadamodar, G.5    Benitez, M.6    Jarvie, T.P.7    Du, L.8    Tomasz, A.9
  • 45
    • 79953222226 scopus 로고    scopus 로고
    • Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence
    • Tsai YK, Fung CP, Lin JC, Chen JH, Chang FY, Chen TL, Siu LK. 2011. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55:1485-1493. http://dx.doi.org/10.1128/AAC.01275-10.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 1485-1493
    • Tsai, Y.K.1    Fung, C.P.2    Lin, J.C.3    Chen, J.H.4    Chang, F.Y.5    Chen, T.L.6    Siu, L.K.7
  • 46
    • 84896702014 scopus 로고    scopus 로고
    • Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems
    • Tsai YK, Liou CH, Fung CP, Lin JC, Siu LK. 2013. Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems. PLoS One 8:e79640. http://dx.doi.org/10.1371/journal.pone.0079640.
    • (2013) PLoS One , vol.8 , pp. e79640
    • Tsai, Y.K.1    Liou, C.H.2    Fung, C.P.3    Lin, J.C.4    Siu, L.K.5
  • 47
    • 33747191088 scopus 로고    scopus 로고
    • In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase
    • Elliott E, Brink AJ, van Greune J, Els Z, Woodford N, Turton J, Warner M, Livermore DM. 2006. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase. Clin Infect Dis 42:e95-98. http://dx.doi.org/10.1086/503264.
    • (2006) Clin Infect Dis , vol.42 , pp. e95-98
    • Elliott, E.1    Brink, A.J.2    Van-Greune, J.3    Els, Z.4    Woodford, N.5    Turton, J.6    Warner, M.7    Livermore, D.M.8
  • 48
    • 33747164276 scopus 로고    scopus 로고
    • Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development
    • Mena A, Plasencia V, Garcia L, Hidalgo O, Ayestaran JI, Alberti S, Borrell N, Perez JL, Oliver A. 2006. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44:2831-2837. http://dx.doi.org/10.1128/JCM.00418-06.
    • (2006) J Clin Microbiol , vol.44 , pp. 2831-2837
    • Mena, A.1    Plasencia, V.2    Garcia, L.3    Hidalgo, O.4    Ayestaran, J.I.5    Alberti, S.6    Borrell, N.7    Perez, J.L.8    Oliver, A.9
  • 49
    • 3843112285 scopus 로고    scopus 로고
    • In vivo acquisition of high-level resistance to imipenem in Escherichia coli
    • Poirel L, Heritier C, Spicq C, Nordmann P. 2004. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 42:3831-3833. http://dx.doi.org/10.1128/JCM.42.8.3831-3833.2004.
    • (2004) J Clin Microbiol , vol.42 , pp. 3831-3833
    • Poirel, L.1    Heritier, C.2    Spicq, C.3    Nordmann, P.4
  • 50
    • 71549148077 scopus 로고    scopus 로고
    • In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment
    • Song W, Suh B, Choi JY, Jeong SH, Jeon EH, Lee YK, Hong SG, Lee K. 2009. In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment. Diagn Microbiol Infect Dis 65:447-449. http://dx.doi.org/10.1016/j.diagmicrobio.2009.08.010.
    • (2009) Diagn Microbiol Infect Dis , vol.65 , pp. 447-449
    • Song, W.1    Suh, B.2    Choi, J.Y.3    Jeong, S.H.4    Jeon, E.H.5    Lee, Y.K.6    Hong, S.G.7    Lee, K.8
  • 51
    • 16244404909 scopus 로고    scopus 로고
    • Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient
    • Thiolas A, Bollet C, La Scola B, Raoult D, Pages JM. 2005. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother 49:1354-1358. http://dx.doi.org/10.1128/AAC.49.4.1354-1358.2005.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 1354-1358
    • Thiolas, A.1    Bollet, C.2    La-Scola, B.3    Raoult, D.4    Pages, J.M.5
  • 54
    • 84870926880 scopus 로고    scopus 로고
    • Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: A review of published case series and case reports
    • Lee GC, Burgess DS. 2012. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob 11:32. http://dx.doi.org/10.1186/1476-0711-11-32.
    • (2012) Ann Clin Microbiol Antimicrob , vol.11 , pp. 32
    • Lee, G.C.1    Burgess, D.S.2
  • 55
    • 61849106980 scopus 로고    scopus 로고
    • Vancomycin heteroresistance and methicillinresistant Staphylococcus aureus
    • Deresinski S. 2009. Vancomycin heteroresistance and methicillinresistant Staphylococcus aureus. J Infect Dis 199:605-609. http://dx.doi.org/10.1086/596630.
    • (2009) J Infect Dis , vol.199 , pp. 605-609
    • Deresinski, S.1
  • 56
    • 38049093421 scopus 로고    scopus 로고
    • Heteroresistance: A concern of increasing clinical significance?
    • Falagas ME, Makris GC, Dimopoulos G, Matthaiou DK. 2008. Heteroresistance: a concern of increasing clinical significance? Clin Microbiol Infect 14:101-104. http://dx.doi.org/10.1111/j.1469-0691.2007.01912.x.
    • (2008) Clin Microbiol Infect , vol.14 , pp. 101-104
    • Falagas, M.E.1    Makris, G.C.2    Dimopoulos, G.3    Matthaiou, D.K.4
  • 57
    • 71549143174 scopus 로고    scopus 로고
    • Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii
    • Ikonomidis A, Neou E, Gogou V, Vrioni G, Tsakris A, Pournaras S. 2009. Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii. J Clin Microbiol 47:4055-4059. http://dx.doi.org/10.1128/JCM.00959-09.
    • (2009) J Clin Microbiol , vol.47 , pp. 4055-4059
    • Ikonomidis, A.1    Neou, E.2    Gogou, V.3    Vrioni, G.4    Tsakris, A.5    Pournaras, S.6
  • 58
    • 0037378068 scopus 로고    scopus 로고
    • Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis
    • Moore MR, Perdreau-Remington F, Chambers HF. 2003. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother 47:1262-1266. http://dx.doi.org/10.1128/AAC.47.4.1262-1266.2003.
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 1262-1266
    • Moore, M.R.1    Perdreau-Remington, F.2    Chambers, H.F.3
  • 59
    • 78650861870 scopus 로고    scopus 로고
    • Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method
    • Satola SW, Farley MM, Anderson KF, Patel JB. 2011. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol 49:177-183. http://dx.doi.org/10.1128/JCM.01128-10.
    • (2011) J Clin Microbiol , vol.49 , pp. 177-183
    • Satola, S.W.1    Farley, M.M.2    Anderson, K.F.3    Patel, J.B.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.